DANIEL A NOTTERMAN
Medical Practice in East Windsor, NJ

License number
New Jersey 25MA03948900
Issued Date
Jan 8, 1981
Expiration Date
Jun 30, 2017
Category
Medical Examiners
Type
Medical Doctor
Address
Address
East Windsor, NJ

Personal information

See more information about DANIEL A NOTTERMAN at radaris.com
Name
Address
Phone
Daniel Notterman
19 Foxcroft Dr, Princeton, NJ 08540
(609) 760-6082
Daniel Notterman, age 72
7 Symmes Ct, Cranbury, NJ 08512
Daniel A Notterman, age 72
19 Foxcroft Dr, Princeton, NJ 08540
(609) 921-2746
(609) 921-3321
Daniel A Notterman
294 Sandpiper Ln, Beach Haven, NJ 08008
Daniel A Notterman
7 Symmes Ct, Cranbury, NJ 08512

Professional information

See more information about DANIEL A NOTTERMAN at trustoria.com
Daniel Notterman Photo 1
Use Of Lecithin:retinol Acyl Transferase Gene Promoter Methylation In Evaluating The Cancer State Of Subject

Use Of Lecithin:retinol Acyl Transferase Gene Promoter Methylation In Evaluating The Cancer State Of Subject

US Patent:
2010014, Jun 10, 2010
Filed:
Dec 19, 2007
Appl. No.:
12/520386
Inventors:
Francis Barany - New York NY, US
Yu-Wei Cheng - Forest Hills NY, US
Philip Paty - New York NY, US
Daniel Notterman - Cranbury NJ, US
Assignee:
CORNELL RESEARCH FOUNDATION, INC. - Ithaca NY
SLOAN KETTERING CANCER CENTER - New York NY
UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY - New Brunswick NJ
International Classification:
A61K 31/27, C12Q 1/68, A61K 31/07, A61K 31/10
US Classification:
514478, 435 6, 514725, 514709
Abstract:
The present invention relates to a method of evaluating the cancer state of a subject using lecithin:retinol acyl transferase (LRAT) gene promoter methylation status. Methods of analyzing and quantifying LRAT gene promoter methylation level are also disclosed. The present invention also relates to methods of determining the prognosis for s subject having cancer by assessing LRAT mRNA expression and LRAT protein expression. Methods of cancer detection, diagnosis, prognosis, and treatment are also disclosed.


Daniel Notterman Photo 2
Methods For Identifying Genes Which Predict Disease Outcome For Patients With Colon Cancer

Methods For Identifying Genes Which Predict Disease Outcome For Patients With Colon Cancer

US Patent:
2011025, Oct 20, 2011
Filed:
Oct 13, 2009
Appl. No.:
13/123689
Inventors:
Francis Barany - New York NY, US
Owen Parker - Brooklyn NY, US
Manny D. Bacolod - Roosevelt Island NY, US
Sarah F. Giardina - New York NY, US
Yu-wei Cheng - Chicago IL, US
Daniel A. Notterman - Cranbury NJ, US
Gunter S. Schemmann - Princeton NJ, US
Philip B. Paty - New York NY, US
Monib Zirvi - Monmouth Junction NJ, US
Assignee:
CORNELL UNIVERSITY - Ithaca NY
THE TRUSTEES OF PRINCETON UNIVERSITY - Princeton NJ
SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH - New York NY
UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY - New Brunswick NJ
International Classification:
C40B 30/04, C40B 40/06, G01N 33/53, C40B 40/08, C12Q 1/68, G01N 33/566
US Classification:
506 9, 435 61, 435 618, 435 617, 436501, 435 612, 435 611, 435 613, 506 17, 506 16
Abstract:
Closures for containers and methods for using same are provided. In a general embodiment/the present disclosure provides a closure having a top portion (), a bottom portion () and a side portion (), an aperture () extending though the closure, a projection () extending from the closure and at least two rib members () on an interior of the projection. The projection may also include a cover (). In another embodiment, a method for using a closure includes inserting a. spike member into a projection, piercing a membrane that hermetically seals a medical container, pushing rib members within the projection to center the spike member inserted into the projection, and tearing the membrane to create a vent hole in the membrane.